https://www.selleckchem.com/pr....oducts/Chlorogenic-a
Nonalcoholic steatohepatitis (NASH) characterizes with massive lipid deposition in hepatocytes and it's often associated with hepatic inflammation and other severe metabolism syndromes. The intervention of NASH can prevent its further progression into hepatocarcinoma. Here, we have successfully constructed a liver-targeted Ce-based hollowed mesoporous nanocarries loaded with a bioactive drugs may offer a satisfactory and effective approach for eliminating NASH. The liver section precise targeting was realized by covalently link